High-throughput assays for promiscuous inhibitors
暂无分享,去创建一个
[1] G. Rishton. Reactive compounds and in vitro false positives in HTS , 1997 .
[2] G S Weston,et al. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. , 1998, Journal of medicinal chemistry.
[3] A. Ghose,et al. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.
[4] Ajay,et al. Recognizing molecules with drug-like properties. , 1999, Current opinion in chemical biology.
[5] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[6] Wolfgang Guba,et al. Development of a virtual screening method for identification of "frequent hitters" in compound libraries. , 2002, Journal of medicinal chemistry.
[7] B. Shoichet,et al. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. , 2002, Journal of medicinal chemistry.
[8] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[9] B. Shoichet,et al. A specific mechanism of nonspecific inhibition. , 2003, Journal of medicinal chemistry.
[10] C. Chung,et al. Effect of detergent on "promiscuous" inhibitors. , 2003, Journal of medicinal chemistry.
[11] Brian K Shoichet,et al. Kinase inhibitors: not just for kinases anymore. , 2003, Journal of medicinal chemistry.
[12] B. Shoichet,et al. Identification and prediction of promiscuous aggregating inhibitors among known drugs. , 2003, Journal of medicinal chemistry.
[13] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[14] Paul J Lewi,et al. Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability. , 2005, Journal of medicinal chemistry.